SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001889
Filing Date
2021-09-27
Accepted
2021-09-27 08:16:06
Documents
17
Period of Report
2021-09-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-20210927.htm   iXBRL 8-K 52275
2 EX-99.1 rare-20210927ex99_1.htm EX-99.1 47216
3 GRAPHIC img259043150_1.jpg GRAPHIC 52537
4 GRAPHIC img259043150_2.jpg GRAPHIC 271622
5 GRAPHIC img259043150_0.jpg GRAPHIC 271622
6 GRAPHIC img259043150_3.jpg GRAPHIC 52537
  Complete submission text file 0000950170-21-001889.txt   1112978

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20210927_lab.xml EX-101.LAB 12798
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20210927.xsd EX-101.SCH 2493
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20210927_pre.xml EX-101.PRE 9457
10 EXTRACTED XBRL INSTANCE DOCUMENT rare-20210927_htm.xml XML 4516
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 211279028
SIC: 2834 Pharmaceutical Preparations